Scarica l'app Stockscreener
12.31
3.98%
-0.51
Dopo l'orario di chiusura:
12.29
-0.02
-0.16%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$12.82
Aprire:
$12.64
Volume 24 ore:
570.34K
Relative Volume:
0.80
Capitalizzazione di mercato:
$369.13M
Reddito:
$36.97M
Utile/perdita netta:
$-25.54M
Rapporto P/E:
-13.64
EPS:
-0.9022
Flusso di cassa netto:
$-24.45M
1 W Prestazione:
+10.11%
1M Prestazione:
+41.82%
6M Prestazione:
-29.25%
1 anno Prestazione:
-12.76%
Intervallo 1D:
$11.99
$12.89
Intervallo di 1 settimana:
$10.71
$13.10
Portata 52W:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Nome
Clearpoint Neuro Inc
Settore
Industria
Telefono
(949) 900-6833
Indirizzo
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
12.31 | 384.42M | 36.97M | -25.54M | -24.45M | -0.9022 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2023-10-24 | Iniziato | Stifel | Buy |
| 2023-02-16 | Ripresa | B. Riley Securities | Buy |
| 2022-04-05 | Ripresa | B. Riley Securities | Buy |
| 2021-03-18 | Iniziato | Lake Street | Buy |
| 2020-07-17 | Iniziato | B. Riley FBR | Buy |
Mostra tutto
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
Stifel Initiates ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $16 - Moomoo
ClearPoint Neuro (CLPT) Receives Buy Rating with $16 Price Targe - GuruFocus
Stifel initiates Clearpoint Neuro stock coverage with buy rating - Investing.com
Stifel initiates Clearpoint Neuro stock coverage with buy rating By Investing.com - Investing.com Canada
CLPT Stock Price, Quote & Chart | CLEARPOINT NEURO INC (NASDAQ:CLPT) - ChartMill
Discipline and Rules-Based Execution in CLPT Response - Stock Traders Daily
ClearPoint Neuro to report first quarter 2026 results on May 13 - Traders Union
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026 - ACCESS Newswire
ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN
ClearPoint Neuro: Temporary Headwinds Don't Change The Long-Term Outlook - Seeking Alpha
ClearPoint Neuro (CLPT) moves 8.1% higher: Will this strength last? - MSN
Here’s why biotech UniQure’s stock just tripled, and brought ClearPoint shares up with it - MSN
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - MSN
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN
ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - Chronicle-Tribune
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint - News-Press NOW
Behavioral Patterns of CLPT and Institutional Flows - Stock Traders Daily
ClearPoint Neuro | DEFA14A: Others - Moomoo
[ARS] ClearPoint Neuro, Inc. SEC Filing - Stock Titan
ClearPoint Neuro completes first procedure with new drill system By Investing.com - Investing.com India
Lake Street Initiates ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $30 - Moomoo
ClearPoint (CLPT): Buy, Sell, or Hold? | Q4 2025: Earnings Fall ShortCommunity Sell Signals - Cổng thông tin điện tử tỉnh Lào Cai
ClearPoint Neuro (CLPT) Achieves Milestone with New Surgical Dri - GuruFocus
ClearPoint Neuro completes first procedure with new drill system - Investing.com
ClearPoint Neuro wins FDA clearance for Velocity Alpha MR High Speed Surgical Drill System - Traders Union
ClearPoint's brain surgery drill gets FDA clearance, first clinical use - Stock Titan
Analysts Offer Insights on Healthcare Companies: Monopar Therapeutics Inc (MNPR), ClearPoint Neuro (CLPT) and CG Oncology, Inc. (CGON) - The Globe and Mail
ClearPoint Neuro Completes First Clinical Procedure with New Surgical Drill - Intellectia AI
CLPT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable - 富途牛牛
ClearPoint Neuro receives Canadian clearance for navigation system By Investing.com - Investing.com India
ClearPoint Neuro gets Canadian approval for navigation system - Investing.com
ClearPoint Neuro (NASDAQ:CLPT) Trading Down 5.3%Should You Sell? - MarketBeat
ClearPoint Neuro gets Canadian approval for navigation system By Investing.com - Investing.com India
ClearPoint Neuro receives Canadian clearance for navigation system - Investing.com
ClearPoint Neuro (CLPT) Receives Medical Device License from Hea - GuruFocus
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug De - PharmiWeb.com
Bigger Capital Group (CLPT) files ownership update showing 7.54% attributed to Michael Bigger - Stock Titan
Clearpoint Neuro Inc Azioni (CLPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):